Symbio Pharmaceuticals Limited(JP:4582)
¥54.00-2.00 (-3.57%)
JP:4582
Symbio Pharmaceuticals Limited Revenue
¥54.00
At close:-2.00 (-3.57%)
Want to see JP:4582 full AI Analyst Report?
Symbio Pharmaceuticals Limited (4582) Revenue
1 Followers
Symbio Pharmaceuticals Limited Revenue
Symbio Pharmaceuticals Limited had a revenue of 236.50M in the quarter ending Jun 30, 2026, with 1.30%. This bring the company's revenue in the last twelve months to 1.13B, Decreased 11.44%. In the fiscal year ending Dec 31, 2025, Symbio Pharmaceuticals Limited had annual revenue of 1.31B with -46.69% growth.
- Revenue (ttm)
- 1.13B
- Revenue Growth
- -30.58%
- P/S Ratio
- 4.32
- Revenue/Employee
- JPY 14,369,758
- Employees
- 91
- Market Cap
- JPY 5.65B
Revenue Chart
Symbio Pharmaceuticals Limited Revenue - Annual
Revenue History
| Fiscal End Date | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.31B | -1.15B | -46.69% |
| Dec 31, 2024 | 2.45B | -3.14B | -56.12% |
| Dec 31, 2023 | 5.59B | -4.42B | -44.15% |
| Dec 31, 2022 | 10.01B | 1.76B | 21.28% |
| Dec 31, 2021 | 8.25B | 5.27B | 176.28% |
| Dec 31, 2020 | 2.99B | 149.30M | 5.26% |
| Dec 31, 2019 | 2.84B | -997.78M | -26.01% |
| Dec 31, 2018 | 3.84B | 391.32M | 11.36% |
| Dec 31, 2017 | 3.44B | ― | ― |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.